Skip to Content
Merck

Key Documents

View All Documentation

WS32

Wright Stain, Modified

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

UNSPSC Code:
41116121
NACRES:
NA.47
MDL number:
MFCD00132590
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

form

solution

Quality Level

500

shelf life

Expiry date on the label.

IVD

for in vitro diagnostic use

concentration

0.3%

technique(s)

microbe id | staining: suitable

pH

6.75-6.95 (25 °C)

application(s)

hematology
histology

storage temp.

room temp

General description

Wright Stain is a polychromatic dye, used for microscopic examination of blood to identify different cell types.

Application

Wright Stain, Modified has been used in hematological assays, to obtain the differential count of leukocytes.
Popular hematology stain used for differentially staining the cellular elements of blood. For dip, rack, and batch staining techniques.

Other Notes

Wright stain, 0.3%, buffered at pH 6.8 in methanol. Contains stabilizers and surfactant.

Still not finding the right product?

Explore all of our products under Wright Stain, Modified

signalword

Danger

Hazard Classifications

Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Eye Irrit. 2 - Flam. Liq. 3 - STOT SE 1

target_organs

Eyes,Central nervous system

Storage Class

3 - Flammable liquids

wgk

WGK 2

flash_point_f

91.4 °F - closed cup

flash_point_c

33 °C - closed cup

ppe

Eyeshields, Faceshields, Gloves, type ABEK (EN14387) respirator filter

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
0000354040
0000332774
SLCR5226
0000288321
0000332774

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Hematology: Clinical Principles and Applications (2007)
A quantitative model for dermal infection and oedema in BALB/c mice pinna
Marino MEN, et al.
BMC Microbiology, 16(1), 290-290 (2016)
Erika Nahomy Marino-Marmolejo et al.
BMC microbiology, 16(1), 290-290 (2016-12-14)
Pharmaceutical industry demands innovation for developing new molecules to improve effectiveness and safety of therapeutic medicines. Preclinical assays are the first tests performed to evaluate new therapeutic molecules using animal models. Currently, there are several models for evaluation of treatments

Global Trade Item Number

SKUGTIN
WS32-1L04061837543616